跳到正文
EDQM 官方新闻与欧洲药典公告·· 14 天前AI 评分44

EDQM新发表BSP研究结果:欧洲药典生长激素CRS第5批的建立

New publication highlights BSP study results for establishment of Somatropin CRS batch 5

AI 导读

欧洲药典生长激素化学对照品(CRS)第5批已于2026年3月由欧洲药典委员会通过,为替代批次。该批次依据EDQM生物标准化计划(BSP)下开展的国际协作研究建立,研究的方法、结果及统计分析已发表于EDQM出版的同行评审期刊Pharmeuropa Bio & Scientific Notes。

正文 · 原文

New publication highlights BSP study results for establishment of Somatropin CRS batch 5

EDQM Strasbourg, France 09/11/2026

Image 6: New publication highlights BSP study results for establishment of Somatropin CRS batch 5

European Pharmacopoeia (Ph. Eur.) Somatropin Chemical Reference Substance (CRS) batch 5 was adopted by the European Pharmacopoeia Commission at its session in March 2026. This replacement batch was established following an international collaborative study conducted under the aegis of the EDQM’s Biological Standardisation Programme. The outcome of this study, including the methodology used, the results obtained and their statistical analysis, has now been published in the online journal Pharmeuropa Bio & Scientific Notes, a peer-reviewed scientific journal published by the EDQM and indexed in MEDLINE.

来源:EDQM 官方新闻与欧洲药典公告 · edqm.eu